Top compounds associated with response to LILRA1


Feature Type Standardized
Nominal ANOVA
mRNA Rapamycin gCSI pan-cancer AAC -0.25 0.0007
mRNA SR8278 CTRPv2 pan-cancer AAC -0.22 0.08
mRNA CIL70 CTRPv2 pan-cancer AAC -0.18 0.0001
mRNA Docetaxel gCSI pan-cancer AAC -0.17 0.02
mRNA CIL41 CTRPv2 pan-cancer AAC -0.17 0.001
mRNA GDC-0941 gCSI pan-cancer AAC -0.16 0.04
mRNA thapsigargin gCSI pan-cancer AAC -0.16 0.03
mRNA paclitaxel gCSI pan-cancer AAC -0.14 0.04
mRNA YM-155 CTRPv2 pan-cancer AAC -0.13 0.0008
mRNA A-770041 GDSC1000 pan-cancer AAC -0.13 0.01
Download CSV